Page 65 - 《中国药房》2023年3期
P. 65

五味子治疗过敏性哮喘的药效物质基础研究
                                                                              Δ


                *
          邴一凡 ,张天雷,孙志伟,杨小龙,李苏楠,姜 雪,曲中原(哈尔滨商业大学药学院,哈尔滨 150076)
                                                              #
          中图分类号  R285.5;R932      文献标志码  A      文章编号  1001-0408(2023)03-0315-06
          DOI  10.6039/j.issn.1001-0408.2023.03.12


          摘  要  目的  研究五味子治疗过敏性哮喘的药效物质基础。方法  运用超高效液相色谱-四极杆飞行时间串联质谱(UPLC-Q-
          TOF-MS/MS)技术分析10批不同产地五味子药材间的共有成分。采用腹腔注射卵白蛋白(OVA)及氢氧化铝刺激结合雾化激发
          的方法建立过敏性哮喘大鼠模型,以一般行为学观察结果和血清中γ干扰素(IFN-γ)、白细胞介素4(IL-4)和免疫球蛋白E(IgE)含
          量作为评价不同产地五味子药材治疗过敏性哮喘药效的指标。同时通过灰色关联度和Pearson相关性分析法分析各批药材共有
          峰峰面积与药效评价指标之间的关联系数,筛选药效物质。结果  从10批不同产地五味子药材中共鉴定出21个共有成分。五味
          子给药后,大鼠呼吸急促、打喷嚏和蜷缩等症状减轻;此外,大鼠血清中IFN-γ含量显著增加(P<0.01),IL-4和IgE含量显著降低
         (P<0.01)。灰色关联度分析结果显示,有 11 个共有成分与 IFN-γ、IL-4 和 IgE 3 个血清药效学指标的关联系数较高( r ˉ>0.8)。
          Pearson相关性分析结果显示,有8个成分与IFN-γ含量呈显著正相关(P<0.05),9、8个成分分别与IL-4和IgE含量呈显著负相关
         (P<0.05)。结合灰色关联度和 Pearson 相关性分析结果,峰 3、4、6、7、9、19、20 等 7 个成分与五味子治疗过敏性哮喘的相关性较
          高。结论  五味子醇甲、五味子乙素、五味子丙素、戈米辛M2、戈米辛J、前戈米辛和当归酰戈米辛H可能为五味子治疗过敏性哮喘
          的潜在药效物质基础。
          关键词  五味子;过敏性哮喘;超高效液相色谱-四极杆飞行时间串联质谱;灰色关联度分析;Pearson相关性分析

          Investigation  of  pharmacodynamic  material  basis  of  Schisandra  chinensis  in  the  treatment  of  allergic
          asthma
          BING Yifan,ZHANG Tianlei,SUN Zhiwei,YANG Xiaolong,LI Sunan,JIANG Xue,QU Zhongyuan(College of
          Pharmacy, Harbin University of Commerce, Harbin 150076, China)

          ABSTRACT   OBJECTIVE  To  study  the  pharmacological  basis  of  Schisandra  chinensis  in  the  treatment  of  allergic  asthma.
          METHODS  The  common  components  of  10  batches  of  S.  chinensis  from  different  habitats  were  analyzed  by  UPLC-Q-TOF-MS/MS.
          Furthermore,  the  allergic  asthma  model  was  established  by  intraperitoneal  injection  of  ovalbumin (OVA)  and  aluminum  hydroxide
          for  stimulation  combined  with  atomization  exitation;  general  behavioral  observation  and  the  contents  of  interferon  γ (IFN- γ),
          interleukin-4 (IL-4)  and  immunoglobulin  E (IgE)  in  serum  were  taken  as  criteria  for  evaluating  the  therapeutic  effect  of  S.
          chinensis from different habitats in the treatment of allergic asthma. Correlation coefficients between common peak area and efficacy
          evaluation index of each batch of medicinal material were analyzed through grey correlation degree and Pearson correlation analysis.
          RESULTS  A  total  of  21  common  components  were  identified  in  10  batches  of  S.  chinensis  from  different  habitats.  After
          administration of S. chinensis, symptoms such as shortness of breath, sneezing and curling of rats were alleviated. In addition, the
          content of IFN-γ was significantly increased while the contents of IL-4 and IgE in serum were distinctly decreased (P<0.01). Grey
          correlation  analysis  showed  that  11  common  components  had  high  correlation  coefficients  with  IFN- γ,  IL-4  and  IgE ( r ˉ>0.8).
          Pearson  correlation  analysis  showed  that  8  components  were  significantly  positively  correlated  with  the  content  of  IFN- γ (P<
          0.05),  and  9,  8  components  were  significantly  negatively  correlated  with  the  content  of  IL-4  and  IgE (P<0.05).  Based  on  the
          results  of  grey  correlation  degree  and  Pearson  correlation  analysis,  7  components  such  as  peak  3,  4,  6,  7,  9,  19  and  20,  were
          highly  related  to  S.  chinensis  in  the  treatment  of  allergic  asthma.  CONCLUSIONS  Schisandrol A,  schisandrin  B,  schisandrin  C,
          gomisin  M2,  gomisin  J,  pregomisin  and  angeloylgomisin  H  are  the  potential  pharmacodynamic  substance  basis  of  S.  chinensis  in
          the treatment of allergic asthma.
          KEYWORDS    Schisandra  chinensis;  allergic  asthma;  UPLC-Q-TOF-MS/MS;  grey  correlation  analysis;  Pearson  correlation
                                                             analysis
             Δ 基金项目 黑龙江省自然科学基金联合引导项目(No.LH2022-
          H001);黑龙江省重点研发计划指导类项目(No.GZ20210110);哈尔滨
          商业大学研究生创新科研资金项目(No.YJSCX2021-721HSD)                   过敏性哮喘是一种机体受到外界抗原性或非抗原
             *第一作者 硕士研究生。研究方向:中药药效物质基础及中药炮                   性刺激产生的气道高反应性呼吸道疾病。目前我国成
          制。E-mail:1941051633@qq.com
                                                             年人的哮喘发病率约为 1.09%,儿童的患病率也在
             # 通信作者 教授,博士生导师,博士。研究方向:中药药效物质基
                                                                       [1]
          础及中药炮制。E-mail:qiuqiuqu@163.com                     3.02%左右 ,这已然成为当下我国面临的重大公共卫生

          中国药房  2023年第34卷第3期                                                 China Pharmacy  2023 Vol. 34  No. 3    · 315 ·
   60   61   62   63   64   65   66   67   68   69   70